Abstract: Disclosed is a pair of medical compression stocking, each comprising a body, an auxiliary pressure part and a present sensing part. The body is formed by means of knitting knitted yarns and inlay yarns. The auxiliary pressure part is integrated with the body, is located at an ankle of a lower limb of each medical compression stocking, and can be in contact with an ankle of a wearer. The pressure sensing part comprises a conducting part and a signal receiving part, wherein the conducting part is integrated with the body and is used for sensing pressure at a corresponding part of the medical compression stocking; and the signal receiving part can receive a signal from the conducting part, and same determines the value of the pressure from the corresponding part according to the signal.

Abstract: The present invention provides methods for identifying agents useful for inhibiting cancer cells by binding to various nuclear receptor proteins, or to the genes or RNA encoding such proteins.

Abstract: The present invention is directed to methods of identifying agents useful for inhibiting cancer cells. The agents bind to one of the proteins described herein, or to a gene or mRNA encoding such protein. The invention is also directed to methods for inhibiting cancer cells by administering an agent that binds to one of the proteins described herein, or to a gene or mRNA encoding such protein.

Abstract: The invention relates to sequence-specific polynucleotide probes, pairs of probes, the design of pairs of probes in relation to the strands of target nucleic acid, and coordinate sequence-specific pairs of polynucleotide primers, and also relates to kits containing such probes, probe pairs, primers, and primer pairs. The invention thus relates to kits and methods employing such polynucleotides. The invention relates to six specific allele discrimination kits. The specific kits are developed for the detection of four single base substitutions in the human CCR2, SDF1, Factor V, MTHFR, Factor XIII genes, and a 32-bp deletion in the human CCR5 gene. The capability of using two allele-specific molecular beacons in the same PCR solution enables the simultaneous determination of three possible allelic representations of a given sequence change in target DNA (Allele 1/Allele 1, Allele 2/Allele 2, Allele 1/Allele 2).